866-997-4948(US-Canada Toll Free)

Antithrombin Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Oct 2017

Category :

Pharmaceutical

No. of Pages : 175 Pages

Global Antithrombin Market – Overview

This report on antithrombin market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing services of antithrombin products such as Antithrombin III, ATryn, and Antithrombin Gama and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global antithrombin market with respect to the leading market segments based on major application segment, source segment, and dosage form segment.

Global Antithrombin Market: Market Segmentation

Based on the application type, the antithrombin market has been segmented into:  therapeutics, research and diagnostics. Each of the market segments have been extensively analyzed based on the market related factors such as increasing demand of antithrombin products worldwide, and technological advancement. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, antithrombin market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Rest of World. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global antithrombin market.

Global Antithrombin Market: Market Dynamics

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the antithrombin market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global antithrombin market.

Global Antithrombin Market: Competitive Landscape

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global antithrombin market. The report also profiles key players operating in the antithrombin market which are rEVO Biologics, Inc., Grifols, Shire plc, CSL Limited, Kedrion S.p.A, Lee Bisolutions, Inc., Scripps Laboratories, Inc., Octapharma AG, Dem ilac Inc. and Diapharma Group, Inc.

The global antithrombin market is segmented as follows:

Global Antithrombin market, by Application

  • Therapeutics
  • Research
  • Diagnostics

Global Antithrombin market, by Source

  • Human
  • Goat Milk
  • Others

 Global Antithrombin market, by Dosage form

  • Lyophilized
  • Liquid

Global Antithrombin market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of the Europe
  • Asia Pacific
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of Latin America
  • Rest of World

Table of Content

1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology

3. Executive Summary
3.1. Global Antithrombin Market Snapshot

4. Market Overview
4.1. Product Overview
4.2. Global Antithrombin Market Size (US$ Mn) Forecast, 2015-2025 
4.3. Key Industry Events 
4.4. Market Opportunity Map
4.5. Porter's Five Forces 
4.6. Global Antithrombin Market Outlook

5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Acceptance of Antithrombin Therapy
5.2.2. Rising prevalence of Hereditary Antithrombin deficiency
5.2.3. Adoption of ATIII in adult ECMO 
5.2.4. New therapeutic Indication
5.2.5. Technological Advancements
5.2.6. Expansion of R&D pipeline of protein/peptide drugs
5.3. Restraints
5.3.1. Use of Substitute & conventional anticoagulants
5.3.2. Pricing Pressure hampering the growth of the market
5.3.3. Increasing complexity of therapeutic is a huge challenge for manufacturers
5.3.4. Lack of regulatory standards
5.4. Global Antithrombin Market Opportunities
5.4.1. Small biotech firms collaborating with large pharmaceutical companies to explore further growth
5.4.2. High potential market opportunity in emerging countries
5.5. Global Antithrombin Market Trends 
5.5.1. Discovering new Indications and exploring use of Antithrombin products 
5.5.2. Upcoming new methods of preparation of Antithrombin products 
5.6. Antithrombin Market Pipeline Analysis – Snapshot
5.7. Antithrombin Market Key Product /Brand Analysis Globally: Snapshot 

6. Global Antithrombin Market Analysis, by Application
6.1. Key Findings 
6.2. Introduction
6.3. Global Antithrombin Market Value Share Analysis, by Application, 2016 -2025
6.3.1. Global Antithrombin Market Forecast, by Application
6.3.2. Global Antithrombin Market Analysis, by Application
6.4. Global Antithrombin Market Attractiveness Analysis, by Application, 2015-2025

7. Global Antithrombin Market Analysis, by Source
7.1. Key Findings 
7.2. Introduction
7.3. Global Antithrombin Market Value Share Analysis, by Source, 2016 -2025
7.3.1. Global Antithrombin Market Forecast, by Source
7.3.2. Global Antithrombin Market Analysis, by Source
7.4. Global Antithrombin Market Attractiveness Analysis, by Source, 2015-2025

8. Global Antithrombin Market Analysis, by Dosage Form
8.1. Key Findings 
8.2. Introduction
8.3. Global Antithrombin Market Value Share Analysis, by Dosage form, 2016 -2025
8.3.1. Global Antithrombin Market Forecast, by Dosage form
8.3.2. Global Antithrombin Market Analysis, by Dosage form
8.4. Global Antithrombin Market Attractiveness Analysis, by Dosage form, 2015-2025

9. Global Antithrombin Market Analysis, by Region
9.1. Global Market Scenario by Country
9.2. Global Antithrombin Market Value Share Analysis, by Region, 2016 and 2025
9.2.1. Global Antithrombin Market Forecast, by Region
9.3. Global Antithrombin Market Attractiveness Analysis, by Region, 2015-2025

10. North America Antithrombin Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. North America Antithrombin Market Value Share Analysis, by Country
10.4. North America Antithrombin Market Forecast, by Country
10.5. North America Antithrombin Market Value Share Analysis, by Application
10.6. North America Antithrombin Market Forecast, by Application
10.7. North America Antithrombin Market Value Share Analysis, by Source
10.8. North America Antithrombin Market Forecast, by Source
10.9. North America Antithrombin Market Value Share Analysis, Dosage Form
10.10. North America Antithrombin Market Forecast, Dosage Form
10.11. North America Antithrombin Market Attractiveness Analysis 

11. Europe Antithrombin Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Europe Antithrombin Market Value Share Analysis, by Country
11.4. Europe Antithrombin Market Forecast, by Country
11.5. Europe Antithrombin Market Value Share Analysis, by Application
11.6. Europe Antithrombin Market Forecast, by Application
11.7. Europe Antithrombin Market Value Share Analysis, by Source
11.8. Europe Antithrombin Market Forecast, by Source
11.9. Europe Antithrombin Market Value Share Analysis, Dosage Form
11.10. Europe Antithrombin Market Forecast, Dosage Form
11.11. Europe Antithrombin Market Attractiveness Analysis 

12. Asia Pacific Antithrombin Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Asia Pacific Antithrombin Market Value Share Analysis, by Country
12.4. Asia Pacific Antithrombin Market Forecast, by Country
12.5. Asia Pacific Antithrombin Market Value Share Analysis, by Application
12.6. Asia Pacific Antithrombin Market Forecast, by Application
12.7. Asia Pacific Antithrombin Market Value Share Analysis, by Source
12.8. Asia Pacific Antithrombin Market Forecast, by Source
12.9. Asia Pacific Antithrombin Market Value Share Analysis, Dosage Form
12.10. Asia Pacific Antithrombin Market Forecast, Dosage Form
12.11. Asia Pacific Antithrombin Market Attractiveness Analysis 

13. LATAM Antithrombin Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. LATAM Antithrombin Market Value Share Analysis, by Country
13.4. LATAM Antithrombin Market Forecast, by Country
13.5. LATAM Antithrombin Market Value Share Analysis, by Application
13.6. LATAM Antithrombin Market Forecast, by Application
13.7. LATAM Antithrombin Market Value Share Analysis, by Source
13.8. LATAM Antithrombin Market Forecast, by Source
13.9. LATAM Antithrombin Market Value Share Analysis, Dosage Form
13.10. LATAM Antithrombin Market Forecast, Dosage Form
13.11. LATAM Antithrombin Market Attractiveness Analysis 

14. Rest of World Antithrombin Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. Rest of World Antithrombin Market Value Share Analysis, by Country
14.4. Rest of World Antithrombin Market Forecast, by Country
14.5. Rest of World Antithrombin Market Value Share Analysis, by Application
14.6. Rest of World Antithrombin Market Forecast, by Application
14.7. Rest of World Antithrombin Market Value Share Analysis, by Source
14.8. Rest of World Antithrombin Market Forecast, by Source
14.9. Rest of World Antithrombin Market Value Share Analysis, Dosage Form
14.10. Rest of World Antithrombin Market Forecast, Dosage Form
14.11. Rest of World Antithrombin Market Attractiveness Analysis 

15. Competition Landscape
15.1. Competition Matrix 
15.2. Antithrombin Market: Heat Map Analysis By Company (2016)
15.3. Company Profiles
15.3.1. rEVO Biologics, Inc. 
15.3.1.1. Company Details
15.3.1.2. Business Overview
15.3.1.3. Financial Overview
15.3.1.4. Strategic Overview
15.3.1.5. SWOT Analysis
15.3.2. Grifols 
15.3.2.1. Company Details
15.3.2.2. Business Overview
15.3.2.3. Financial Overview
15.3.2.4. Strategic Overview
15.3.2.5. SWOT Analysis
15.3.3. Shire plc 
15.3.3.1. Company Details
15.3.3.2. Business Overview
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. CSL Limited 
15.3.4.1. Company Details
15.3.4.2. Business Overview
15.3.4.3. Financial Overview
15.3.4.4. Strategic Overview
15.3.4.5. SWOT Analysis
15.3.5. Kedrion S.p.A. 
15.3.5.1. Company Details
15.3.5.2. Business Overview
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Octapharma AG 
15.3.6.1. Company Details
15.3.6.2. Business Overview
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Dem ilac, Inc. 
15.3.7.1. Company Details
15.3.7.2. Business Overview
15.3.7.3. Financial Overview
15.3.7.4. Strategic Overview
15.3.7.5. SWOT Analysis
15.3.8. Lee Bisolutions, Inc. 
15.3.8.1. Company Details
15.3.8.2. Business Overview
15.3.8.3. Financial Overview
15.3.8.4. Strategic Overview
15.3.8.5. SWOT Analysis
15.3.9. Diapharma Group, Inc. 
15.3.9.1. Company Details
15.3.9.2. Business Overview
15.3.9.3. Financial Overview
15.3.9.4. Strategic Overview
15.3.9.5. SWOT Analysis
15.3.10. Scripps Laboratories, Inc. 
15.3.10.1. Company Details
15.3.10.2. Business Overview
15.3.10.3. Financial Overview
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis
15.4. Other Prominent Companies

List of Table

Table 01: Global Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 02: Global Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 03: Global Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 04: Global Antithrombin Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 05: North America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 06: North America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 07: North America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 08: North America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 09: Europe Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 11: Europe Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 12: Europe Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 13: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 15: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 16: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 17: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 19: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 20: Latin America Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025
Table 21: Rest of the World Antithrombin Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 22: Rest of the World Antithrombin Market Size (US$ Mn) Forecast, by Source, 2015–2025
Table 23: Rest of the World Antithrombin Market Size (US$ Mn) Forecast, by Dosage Form, 2015–2025

List of Chart

Figure 01: Global Antithrombin Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Market Value Share, by Region (2016)
Figure 03: Market Value Share, by Application (2016)
Figure 04: Market Value Share, by Source (2016)
Figure 05: Market Value Share, by Dosage Form (2016)
Figure 06: Global Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 07: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015–2025
Figure 08: Global Antithrombin Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research, 2015–2025
Figure 09: Global Antithrombin Market Revenue (US$ Mn) and
Figure 10: Global Antithrombin Market Attractiveness Analysis, by Application, 2017–2025
Figure 11: Global Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 12: Global Antithrombin Market Revenue (US$ Mn), by Human Source, 2015–2025
Figure 13: Global Antithrombin Market Revenue (US$ Mn), by Goat Milk Source, 2015–2025
Figure 14: Global Antithrombin Market Revenue (US$ Mn), by Others, 2015–2025
Figure 15: Global Antithrombin Market Attractiveness Analysis, by Source, 2015–2025
Figure 16: Global Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 17: Global Antithrombin Market Revenue (US$ Mn), by Lyophilized Dosage Form, 2015–2025
Figure 18: Global Antithrombin Market Revenue (US$ Mn), by Liquid Dosage Form, 2015–2025
Figure 19: Global Antithrombin Market Attractiveness Analysis, by Dosage Form, 2015–2025
Figure 20: Global Antithrombin Market Value Share Analysis, by Region, 2016 and 2025
Figure 21: Global Antithrombin Market Attractiveness Analysis, by Region, 2015–2025 
Figure 22: North America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 23: North America Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 24: North America Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 25: North America Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 26: North America Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 27: North America Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 28: North America Antithrombin Market Attractiveness Analysis, by Application,
Figure 29: North America Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 30: North America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 31: Europe Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 32: Europe Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 33: Europe Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 34: Europe Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 35: Europe Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 36: Europe Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 37: Europe Antithrombin Market Attractiveness Analysis, by Application,
Figure 38: Europe Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 39: Europe Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 40: Asia Pacific Antithrombin Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 41: Asia Pacific Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 42: Asia Pacific Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 43: Asia Pacific Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 44: Asia Pacific Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 45: Asia Pacific Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 46: Asia Pacific Antithrombin Market Attractiveness Analysis, by Application, 2017–2025
Figure 47: Asia Pacific Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 48: Asia Pacific Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 49: Latin America Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 50: Latin America Antithrombin Market Attractiveness Analysis, by Country, 2017–2025
Figure 51: Latin America Antithrombin Market Value Share Analysis, by Country, 2016 and 2025
Figure 52: Latin America Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 53: Latin America Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 54: Latin America Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 55: Latin America Antithrombin Market Attractiveness Analysis, by Application,
Figure 56: Latin America Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 57: Latin America Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 58: Rest of the World Antithrombin Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 59: Rest of the World Antithrombin Market Value Share Analysis, by Application, 2016 and 2025
Figure 60: Rest of the World Antithrombin Market Value Share Analysis, by Source, 2016 and 2025
Figure 61: Rest of the World Antithrombin Market Value Share Analysis, by Dosage Form, 2016 and 2025
Figure 62: Rest of the World Antithrombin Market Attractiveness Analysis, by Application, 2017–2025
Figure 63: Rest of the World Antithrombin Market Attractiveness Analysis, by Source, 2017–2025
Figure 64: Rest of the World Antithrombin Market Attractiveness Analysis, by Dosage Form, 2017–2025
Figure 65: Heat Map Analysis by Company (2016)
Figure 66: Revenue for the LFB Group (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 67: Breakdown of Net Sales, by Business Segment, 2016
Figure 68: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 69: Breakdown of Net Sales, by Business Segment, 2016
Figure 70: Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2016
Figure 71: Breakdown of Net Sales, by Region, 2016
Figure 72: CSL Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 73: Breakdown of Net Sales by Business segments, 2016
Figure 74: Company Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016
Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *